z-logo
open-access-imgOpen Access
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
Author(s) -
Christine Danel,
Raoul Moh,
Delphine Gabillard,
Anani Badje,
Jérôme Le Carrou,
Timothée Ouassa,
Eric Ouattara,
Amani Anzian,
Jean-Baptiste Ntakpé,
Alber Minga,
Gérard M Kouame,
Franck Bouhoussou,
Arlette Emieme,
Antoine Kouamé,
André Inwoley,
Thomas-d'Aquin Toni,
Hugues Ahiboh,
Mathieu Kabran,
Cyprien Rabe,
Baba Sidibé,
Gustave Nzunetu,
Romuald Konan,
Joachim Gnokoro,
Patrice Gouesse,
Eugène Messou,
Lamber Dohoun,
Synali Kamagate,
Abo Yao,
Solange Amon,
Amadou-Barenson Kouame,
Aboli Koua,
Emmanuel Kouamé,
Yao Ndri,
Olivier Ba-Gomis,
Marcelle Daligou,
Simplice Ackoundzé,
Denise Hawerlander,
Alex Ani,
Fassery Dembélé,
Fatoumata Koné,
Calixte Guéhi,
Constance Kanga,
Serge Koule,
Jonas Séri,
Mykayila Oyebi,
Nathalie Mbakop,
Olewole Makaila,
Carole Babatunde,
Nathanael Babatounde,
Gisèle Bleoué,
Mireille Tchoutedjem,
Alain-Claude Kouadio,
Ghislaine Sena,
Sahinou-Yediga Yededji,
Rodrigue Assi,
Alima Bakayoko,
Alassane Mahassadi,
Alain Attia,
Armel Oussou,
Max Mobio,
Doféré Bamba,
Mesmin Koman,
Apollinaire Horo,
Nina Deschamps,
Henri Chenal,
Madeleine Sassan-Morokro,
Seidou Konate,
Kakou Aka,
Eba Aoussi,
Valérie Journo,
Célestin Ncho,
Sophie Karcher,
Marie-Laure Chaix,
Christine Rouzioux,
Papa-Salif Sow,
Christian Perronne,
Pierre-Marie Girard,
Hervé Menan,
Emmanuel Bissagnene,
Auguste Kadio,
Virginie Ettiegne-Traore,
Corinne Moh-Semdé,
Abo Kouame,
Jean-Marie Massumbuko,
Geneviève Chêne,
Mireille Dosso,
Serge K Domoua,
Thérèse N'Dri-Yoman,
Roger Salamon,
Serge P Eholié,
Xavier Anglare
Publication year - 2015
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1507198
Subject(s) - medicine , isoniazid , tuberculosis , confidence interval , antiretroviral therapy , pediatrics , human immunodeficiency virus (hiv) , viral load , immunology , pathology
In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)-associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess the benefits of early antiretroviral therapy (ART), 6-month isoniazid preventive therapy (IPT), or both among HIV-infected adults with high CD4+ cell counts in Ivory Coast.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom